PROTEIN INTERACTION CORE

蛋白质相互作用核心

基本信息

项目摘要

DESCRIPTION: In a post-genomic era, systems analyses have revealed interconnected networks between gene products. Such networks predict the relationship between interacting proteins and group proteins into clusters to facilitate definition of protein function. Understanding networks of protein-protein interactions in the brain will undoubtedly lead to a better understanding of neurological diseases and identify new targets for therapeutic agents. Several large scale projects have used high throughput yeast two hybrid (Y2H) analyses to identify interacting products of open reading frames (ORES) of an organism. Functionally important protein interaction networks were defined and, for C elegans, it was shown that essential proteins often interact with one another ^^¿^^. Similar analyses are useful for discovering common mechanisms of disorders of CNS development as illustrated by a recent study that examined a protein interaction network of cerebellar ataxias by Y2H and networking analyses ^^. The power of the Y2H approach in elucidating pathogenic mechanisms of neurodegenerative disorders is remarkable. Many human neurodegenerative, developmental, and cognitive function disorders have been associated with multiple alleles. Multiple genes or genetic loci have also been implicated in complex disorders such as autism ^¿. Linkage analysis suggests that many genetic loci are associated with autism and it is conceivable that the genes associated with autism could interconnect, having effects on similar cellular pathways (13-14,19). In addition, studies of diseases associated with a single gene have also benefited from studies of protein interactions. It is estimated that -80% of disease-associated SNPs destabilize a protein's structure and thereby may alter interactions with other proteins (2,38,41). Efforts to understand how protein interactions mediate complex biological processes are maior components of the research goals of NINDS supported investigators at UAB. Core C will facilitate progress in these areas. We propose to maintain a Protein Interaction Core that offers expression of proteins in both prokaryotic and eukaryotic expression systems suitable for protein purification in-vitro and expression in-vivo, vector design and selection for in-vitro and in-vivo expression, biochemical and imaging characterization of protein interactions including FRET and split luciferase/GFP, yeast two-hybrid screening systems and generation of constructs for tandem affinity purification (TAP) and mass spectroscopy. The goal of the Core Laboratory is to accelerate identification and characterization of biologically important protein interactions without the need to establish these methodologies in individual NINDS supported laboratories. The Core Laboratory personnel will assist investigators in selection of appropriate screening systems, generate expression vector constructs for screening assays, and provide troubleshooting and technical assistance in the screening procedures. The Core Laboratory will also facilitate the exchange of reagents and more importantly, expand an information and reagent sharing resource (www.neurosciencecore.uab.edu/coreclinks.htm ) that will permit individual laboratories to share relevant experience with protein expression systems and interacting protein screening systems with other NINDS supported investigators at UAB. Finally, the core laboratory will limit redundancy in development of these methodologies and permit more efficient use of the resources provided by NINDS to investigate protein function in complex biologic systems that are the focus of study by NINDS supported investigators at UAB. Table 1 provides several examples of the interaction of the Protein Interaction Core Core C) with NINDS supported UAB investigators.
描述:在后基因组时代,系统分析揭示了基因产物之间的互连网络。这种网络预测相互作用的蛋白质和将蛋白质分组成簇之间的关系,以促进蛋白质功能的定义。了解大脑中蛋白质-蛋白质相互作用的网络无疑将有助于更好地了解神经系统疾病并确定治疗药物的新靶点。 几个大型项目已使用高通量酵母二杂种 (Y2H) 分析来识别生物体开放阅读框 (ORES) 的相互作用产物。功能上重要的蛋白质相互作用网络已被定义,并且对于秀丽隐杆线虫而言,研究表明必需蛋白质经常彼此相互作用^^¿^^。 类似的分析对于发现中枢神经系统发育障碍的常见机制很有用,正如最近的一项研究所说明的那样,该研究通过 Y2H 和网络分析检查了小脑共济失调的蛋白质相互作用网络 ^^。 Y2H 方法在阐明神经退行性疾病致病机制方面的力量是显着的。 许多人类神经退行性、发育和认知功能障碍与多个等位基因有关。多个基因或遗传位点也与自闭症等复杂疾病有关。连锁分析表明,许多基因位点与自闭症有关,可以想象, 与自闭症相关的基因可以相互连接,对相似的细胞通路产生影响 (13-14,19)。此外,与单个基因相关的疾病的研究也受益于蛋白质相互作用的研究。据估计,-80% 的疾病相关 SNP 会破坏蛋白质结构的稳定性,从而可能改变 与其他蛋白质的相互作用 (2,38,41)。努力了解蛋白质相互作用如何介导复杂的生物过程是 NINDS 支持的 UAB 研究人员研究目标的主要组成部分。 核心 C 将促进这些领域的进展。 我们建议维护一个蛋白质相互作用核心,该核心可在原核和真核表达系统中提供蛋白质表达,适用于蛋白质体外纯化和体内表达、体外和体内表达的载体设计和选择、蛋白质的生化和成像表征 相互作用,包括 FRET 和分裂荧光素酶/GFP、酵母双杂交筛选系统以及用于串联亲和纯化 (TAP) 和质谱的构建体的生成。核心实验室的目标是加速生物学上重要的蛋白质相互作用的识别和表征,而无需 在 NINDS 支持的各个实验室中建立这些方法。核心实验室人员将协助研究人员选择合适的筛选系统,生成用于筛选测定的表达载体构建体,并在筛选程序中提供故障排除和技术援助。这 核心实验室还将促进试剂交换,更重要的是,扩大信息和试剂共享资源(www.neurosciencecore.uab.edu/coreclinks.htm),这将允许个人 实验室与 UAB 的其他 NINDS 支持的研究人员分享蛋白质表达系统和相互作用蛋白质筛选系统的相关经验。最后,核心实验室将限制这些方法开发中的冗余,并允许更有效地利用 NINDS 提供的资源来研究复杂生物系统中的蛋白质功能,这是 NINDS 支持的 UAB 研究人员的研究重点。表 1 提供了蛋白质相互作用核心核心 C) 与 NINDS 支持的 UAB 研究人员相互作用的几个示例。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Jarvis Britt其他文献

William Jarvis Britt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Jarvis Britt', 18)}}的其他基金

Tegument Envelope Protein Interactions in CMV Envelopment
CMV 包膜中的皮膜包膜蛋白相互作用
  • 批准号:
    10573700
  • 财政年份:
    2022
  • 资助金额:
    $ 20.02万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10019411
  • 财政年份:
    2019
  • 资助金额:
    $ 20.02万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10488568
  • 财政年份:
    2019
  • 资助金额:
    $ 20.02万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
  • 批准号:
    10686167
  • 财政年份:
    2019
  • 资助金额:
    $ 20.02万
  • 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation (Vision and auditory screening in infants born to women enrolled in ZIP)
CMV 疫苗:再感染和抗原变异(参加 ZIP 的妇女所生婴儿的视力和听觉筛查)
  • 批准号:
    9472616
  • 财政年份:
    2017
  • 资助金额:
    $ 20.02万
  • 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
  • 批准号:
    9759910
  • 财政年份:
    2017
  • 资助金额:
    $ 20.02万
  • 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
  • 批准号:
    10238050
  • 财政年份:
    2017
  • 资助金额:
    $ 20.02万
  • 项目类别:
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV miRNA 对病毒装配室的分泌和形成的调节
  • 批准号:
    9883699
  • 财政年份:
    2016
  • 资助金额:
    $ 20.02万
  • 项目类别:
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV miRNA 对病毒装配室的分泌和形成的调节
  • 批准号:
    9250666
  • 财政年份:
    2016
  • 资助金额:
    $ 20.02万
  • 项目类别:
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
先天性巨细胞病毒和中枢神经系统感染的保护性免疫机制
  • 批准号:
    8450754
  • 财政年份:
    2011
  • 资助金额:
    $ 20.02万
  • 项目类别:

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 20.02万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 20.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了